These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
557 related items for PubMed ID: 19057397
21. Conversion from calcineurin inhibitors to sirolimus in kidney transplant recipients: a retrospective cohort study. Cardinal H, Froidure A, Dandavino R, Daloze P, Hébert MJ, Colette S, Boucher A. Transplant Proc; 2009 Oct; 41(8):3308-10. PubMed ID: 19857737 [Abstract] [Full Text] [Related]
23. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease. Stephany BR, Boumitri M, Budev M, Alao B, Poggio ED. J Heart Lung Transplant; 2009 Jun; 28(6):564-71. PubMed ID: 19481016 [Abstract] [Full Text] [Related]
24. Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus. Casas-Melley AT, Falkenstein KP, Flynn LM, Ziegler VL, Dunn SP. Pediatr Transplant; 2004 Aug; 8(4):362-6. PubMed ID: 15265163 [Abstract] [Full Text] [Related]
25. Conversion from sirolimus to everolimus in kidney transplant recipients receiving a calcineurin-free regimen. Carvalho C, Coentrão L, Bustorff M, Patrício E, Sampaio S, Santos J, Oliveira G, Pestana M. Clin Transplant; 2011 Aug; 25(4):E401-5. PubMed ID: 21457330 [Abstract] [Full Text] [Related]
26. Protocol conversion from a calcineurin inhibitor based therapy to sirolimus. Oberbauer R. Transplantation; 2009 Apr 27; 87(8 Suppl):S7-10. PubMed ID: 19384186 [Abstract] [Full Text] [Related]
27. Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation. Yang YJ, Li LX, He Q, Fan H, Jin ZK, Lang R, Kou JT, Li P, Xie DH, Chen DZ. Hepatobiliary Pancreat Dis Int; 2007 Aug 27; 6(4):376-8. PubMed ID: 17690032 [Abstract] [Full Text] [Related]
29. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy. Luna E, Cerezo I, Macias R, Villa J, Martinez C, Cubero J, Martinez R, Ferreira F, García C. Transplant Proc; 2011 Aug 27; 43(6):2187-90. PubMed ID: 21839229 [Abstract] [Full Text] [Related]
32. Proteinuria after conversion to sirolimus in renal transplant recipients. Sahin GM, Sahin S, Kantarci G, Ergin H. Transplant Proc; 2006 Dec 27; 38(10):3473-5. PubMed ID: 17175308 [Abstract] [Full Text] [Related]
33. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy. Falger JC, Mueller T, Arbeiter K, Boehm M, Regele H, Balzar E, Aufricht C. Pediatr Transplant; 2006 Jun 27; 10(4):474-8. PubMed ID: 16712606 [Abstract] [Full Text] [Related]
37. Sirolimus as an alternative to anticalcineurin therapy in heart transplantation: experience of a single center. Fernandez-Valls M, Gonzalez-Vilchez F, de Prada JA, Ruano J, Ruisanchez C, Martin-Duran R. Transplant Proc; 2005 Nov 27; 37(9):4021-3. PubMed ID: 16386615 [Abstract] [Full Text] [Related]
39. Sirolimus therapy in liver transplant patients: an initial experience at a single center. Nocera A, Andorno E, Tagliamacco A, Morelli N, Bottino G, Ravazzoni F, Casaccia M, Barocci S, Alice S, Santori G, Ghirelli R, Valente U. Transplant Proc; 2008 Nov 27; 40(6):1950-2. PubMed ID: 18675098 [Abstract] [Full Text] [Related]